← Back to headlines
New Pancreatic Cancer Pill Shows Promise in Early Trials
Early trial results for a new daily pill, daraxonrasib, are showing significant promise in treating advanced pancreatic cancer in patients with RAS mutations.
18 May, 11:00 — 18 May, 11:00
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Revolutionary Discovery: Baby's Brain Trains in Womb to Recognize the World
14m ago
Montenegro Debates Geological Research Law Amid Earthquake Safety Concerns
17m ago
Five Italian Divers Die in Maldives Cave Tragedy
21m ago